ZARXIO prefilled syringe
ZARXIO administration video
For caregivers and patients. How to prepare for an injection, give the injection, and how to store and dispose of ZARXIO.
How to Administer ZARXIO
ZARXIO is available with a BD UltraSafe Passive® Needle Guard that provides one-handed passive activation.1
Not actual size.
ZARXIO is available in prefilled syringes, in the same 2 dosage strengths as
NEUPOGEN® (filgrastim) and has an identical dosing schedule and route of administration to NEUPOGEN®.1,2
ZARXIO is administered by subcutaneous injection, short intravenous infusion (15 to 30 minutes)‚ or continuous intravenous infusion.1
You should not inject a dose of ZARXIO less than 0.3 mL (180 mcg) from a ZARXIO prefilled syringe. A dose less than 0.3 mL cannot be accurately measured using the ZARXIO prefilled syringe.1
References: 1. ZARXIO Prescribing Information. Sandoz Inc. February 2017. 2. NEUPOGEN® Prescribing Information. Amgen Inc. June 2016.
ZARXIO is a registered trademark of Novartis AG.
NEUPOGEN is a registered trademark of Amgen Inc.
UltraSafe Passive is a registered trademark of Safety Syringes, Inc.